What Is Stroma Fundamentals Functions And Biomedical Significance

Published

Table of Contents

The stroma represents a fundamental yet often underappreciated component of cellular biology, serving as the dynamic matrix where critical biochemical processes unfold. In plant cells, it functions as the liquid-filled space surrounding thylakoids within chloroplasts, orchestrating photosynthesis by housing enzymes essential for carbon fixation and metabolic regulation. Beyond its photosynthetic role, stroma extends its influence into eukaryotic and prokaryotic systems, where it adapts structurally and functionally to support energy production, tissue architecture, and even disease pathology. From its molecular composition—enriched with enzymes, metabolites, and transport proteins—to its integration with broader cellular networks, stroma emerges as a pivotal player in both natural and engineered biological systems.

This exploration examines stroma’s core characteristics, its diverse roles across organisms, and its implications in medical research and biotechnology. By dissecting its biochemical pathways, metabolic contributions, and adaptive mechanisms, we reveal how stroma not only sustains life but also presents opportunities for therapeutic innovation and industrial applications. The interplay between its structural versatility and functional precision underscores its indispensable role in cellular physiology, bridging fundamental science with cutting-edge advancements.

what is stroma

Definition and Core Characteristics of Stroma

The stroma represents a fundamental semi-fluid matrix within chloroplasts of plant cells and certain algae, serving as the site for critical biochemical reactions essential to cellular metabolism. Unlike other cellular structures such as the cytoplasm or vacuoles, the stroma is enclosed within the inner membrane of the chloroplast and is distinct in its composition, primarily consisting of proteins, enzymes, DNA (circular chloroplast DNA), ribosomes, and metabolites. Its unique biochemical environment facilitates processes that sustain both photosynthetic and non-photosynthetic functions, distinguishing it from analogous structures in animal cells.

The stroma’s primary role in plant cells extends beyond photosynthesis to include the synthesis of organic molecules, such as amino acids, fatty acids, and nucleotides, through the Calvin cycle and other metabolic pathways. Its interaction with thylakoid membranes—where the light-dependent reactions of photosynthesis occur—creates a dynamic system for energy conversion and carbon fixation. Below, the structural and functional distinctions between plant and animal stroma are outlined, followed by an analysis of its biochemical interplay with thylakoids.

Structural and Functional Definition of Stroma in Plant Cells

The stroma is a dense, aqueous phase occupying approximately 50% of the chloroplast’s volume, surrounded by the inner chloroplast membrane. Its composition includes:
  • Enzymes: Over 30 enzymes participate in the Calvin cycle, including ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco), the most abundant enzyme on Earth.
  • Chloroplast DNA (cpDNA): Encodes proteins for chloroplast function, such as ribosomal RNA and photosynthetic proteins.
  • Ribosomes (70S type): Synthesize proteins required for chloroplast maintenance and function.
  • Metabolites: Stores intermediates like glucose-6-phosphate, glyceraldehyde-3-phosphate (G3P), and starch granules.
  • The stroma’s fluidity and enzyme concentration enable efficient substrate diffusion and catalytic activity, distinguishing it from the rigid cytoskeletal structures in animal cells.

    Comparative Analysis: Stroma in Plant vs. Animal Cells

    While the term stroma is also used in animal cells (e.g., the extracellular matrix or nuclear stroma), its role and composition differ significantly from that of chloroplast stroma. The following table contrasts these structures:
    Feature Plant Chloroplast Stroma Animal Cell Stroma (e.g., Nuclear Stroma)
    Location Within the inner membrane of chloroplasts, enclosed by thylakoids. Within the nuclear envelope (nuclear stroma) or extracellular matrix (e.g., connective tissue).
    Primary Function
    • Carbon fixation via Calvin cycle.
    • Synthesis of amino acids, lipids, and nucleotides.
    • Starch and sucrose production.
    • Structural support (extracellular matrix).
    • Regulation of gene expression (nuclear stroma).
    • Signal transduction (e.g., integrin-mediated pathways).
    Biochemical Composition
    • High concentration of enzymes (e.g., Rubisco, sedoheptulose-1,7-bisphosphatase).
    • Contains cpDNA and 70S ribosomes.
    • Rich in metabolites (e.g., ATP, NADPH, G3P).
    • Proteins (e.g., lamins, histones), glycoproteins, and polysaccharides.
    • Lacks photosynthetic enzymes or cpDNA.
    • Contains cytoskeletal elements (e.g., intermediate filaments).
    Energy Coupling Depends on ATP and NADPH produced in thylakoid lumen via light-dependent reactions. Relies on mitochondrial ATP or glycolytic pathways (no direct photosynthetic coupling).
    Evolutionary Origin Derived from cyanobacterial endosymbiosis (~1.5 billion years ago). Evolved from eukaryotic cellular components (e.g., nuclear envelope invagination).
    Key Insight: The plant chloroplast stroma is a specialized compartment for autotrophic metabolism, whereas animal stroma primarily serves structural or regulatory roles without photosynthetic capacity.

    Biochemical Interaction Between Stroma and Thylakoids in Photosynthesis

    The stroma and thylakoids form a functionally integrated system where light energy is converted into chemical energy via two interconnected phases: the light-dependent reactions (thylakoid lumen) and the light-independent reactions (stroma). This interplay is governed by the following pathways:

    1. Electron Transport Chain (ETC) and ATP Synthesis
    The thylakoid membrane hosts photosystems I and II, which capture photons to split water (photolysis), releasing oxygen and protons into the lumen. The resulting proton gradient drives ATP synthesis via CF0-CF1 ATP synthase, pumping ATP into the stroma. This ATP, along with NADPH (produced by ferredoxin-NADP+ reductase), powers the Calvin cycle.

    Photophosphorylation Pathway:
    1. Light absorption by chlorophyll → Excitation of electrons in PSII.
    2. Water oxidation → O2 release + H+ accumulation in lumen.
    3. Proton gradient → ATP synthesis via CF0-CF1.
    4. NADP+ reduction to NADPH by ferredoxin.
    2. Carbon Fixation via the Calvin Cycle
    The stroma hosts the Calvin-Benson-Bassham (CBB) cycle, a series of enzymatic reactions that fix CO2 into organic molecules. The cycle requires:
  • CO2 (from atmosphere or photorespiration).
  • ATP and NADPH (from thylakoid reactions).
  • Rubisco (catalyzes carboxylation of ribulose-1,5-bisphosphate, RuBP).
  • The cycle produces G3P, a precursor for glucose, starch, and cellulose. Excess G3P is exported to the cytoplasm for sucrose synthesis or stored as starch granules within the stroma.

    Calvin Cycle Phases:
    1. Carboxylation: CO2 + RuBP → 3-phosphoglycerate (3-PGA) (catalyzed by Rubisco).
    2. Reduction: 3-PGA + ATP + NADPH → G3P.
    3. Regeneration: G3P → RuBP (requires ATP).
    3. Metabolic Cross-Talk
    The stroma also interfaces with other chloroplast pathways, such as:
  • Photorespiration: A competing pathway where Rubisco oxygenates RuBP, producing glycolate (detrimental in C3 plants). Peroxisomes and mitochondria collaborate to recycle glycolate back into 3-PGA.
  • Fatty Acid and Amino Acid Synthesis: Enzymes in the stroma (e.g., acetyl-CoA carboxylase) convert G3P into lipids, while others synthesize amino acids like serine and glycine.
  • Example: In C4 plants, the stroma of bundle-sheath cells (a specialized chloroplast type) becomes the primary site for CO2 fixation via the Hatch-Slack pathway, minimizing photorespiration by concentrating CO2 via malate transport.

    Regulation of Stromal Biochemistry

    The stroma’s metabolic activity is tightly regulated through:
  • Enzyme Activation/Inhibition: Light-dependent phosphorylation of enzymes (e.g., Rubisco activase) enhances Calvin cycle efficiency.
  • pH and Redox State: Thylakoid proton pumping acidifies the lumen, while the stroma remains alkaline (pH ~8), optimizing enzyme function.
  • Substrate Availability: CO2 concentration (via stomatal regulation) and NADPH/ATP ratios dictate cycle flux.
  • Example: During darkness, the stroma’s enzymes are deactivated, and starch is degraded into maltose for export, ensuring metabolic flexibility.

    Stroma in Different Organisms and Tissues

    The stroma represents a fundamental structural and functional component across diverse biological systems, exhibiting significant variations in composition, organization, and physiological roles. While its presence in photosynthetic eukaryotes (e.g., chloroplasts) is well-documented, stroma also plays critical roles in non-photosynthetic cells, tissues, and organisms, reflecting evolutionary adaptations to metabolic, structural, and environmental demands. Prokaryotes and eukaryotes demonstrate distinct stromal architectures, each optimized for their cellular environment, while specialized tissues in multicellular organisms rely on stromal contributions to maintain homeostasis, mechanical integrity, and biochemical compartmentalization.

    Structural and functional adaptations of stroma vary markedly between prokaryotic and eukaryotic cells, with prokaryotes lacking membrane-bound organelles and instead relying on a nucleoid-associated region and a cytoplasmic matrix to organize genetic material and metabolic pathways. In contrast, eukaryotic cells compartmentalize stroma within organelles such as chloroplasts, mitochondria, and the endoplasmic reticulum, enabling spatial regulation of biochemical processes. These differences underscore the evolutionary trade-offs between simplicity and specialization.

    Stromal Variations in Prokaryotic vs. Eukaryotic Cells

    In prokaryotes, the cytoplasmic stroma serves as the primary site for metabolic reactions, including glycolysis, the citric acid cycle, and protein synthesis. The absence of membrane-bound organelles necessitates a highly organized cytoplasmic matrix, where nucleoid-associated proteins (NAPs) and small molecules (e.g., polyamines, ions) regulate DNA supercoiling, transcription, and ribosome assembly. For instance, Escherichia coli employs a condensed nucleoid region surrounded by a viscous cytoplasmic stroma, facilitating efficient nutrient uptake and rapid response to environmental changes.

    Eukaryotic cells, however, exhibit a compartmentalized stroma within organelles, each with distinct biochemical functions:

  • Chloroplast stroma: Contains enzymes for the Calvin cycle, DNA, and ribosomes, enabling autonomous protein synthesis and carbon fixation.
  • Mitochondrial matrix (stroma): Houses the TCA cycle, fatty acid oxidation, and mitochondrial DNA replication, with a dense protein milieu optimized for oxidative phosphorylation.
  • Endoplasmic reticulum (ER) lumen stroma: Specialized for protein folding (rough ER) and lipid synthesis (smooth ER), with a redox-active environment maintained by chaperones and disulfide isomerases.
  • The eukaryotic stroma’s complexity arises from membrane-bound compartmentalization, allowing spatial separation of conflicting pathways (e.g., oxidative phosphorylation vs. anabolic reactions) and fine-tuned regulation via organelle-specific signals (e.g., calcium gradients in the ER).

    Key Tissues and Organs Where Stroma Plays a Critical Role

    Stroma is not limited to photosynthetic or mitochondrial systems; it underpins the structural and functional integrity of numerous tissues and organs across kingdoms. Below are systems where stromal contributions are indispensable:
    • Liver (Hepatic Stroma)
      The liver’s extracellular matrix (ECM) and interstitial stroma provide mechanical support, regulate blood flow, and facilitate metabolic zonation. Hepatic stellate cells (HSCs) within the stroma store vitamin A and, upon activation, secrete collagen fibers, contributing to fibrosis in chronic liver diseases. The space of Disse, a stromal compartment between hepatocytes and sinusoidal endothelial cells, enables nutrient exchange and detoxification.
    • Kidney (Renal Interstitium and Glomerular Stroma)
      The kidney’s interstitial stroma maintains osmotic gradients, houses immune cells, and regulates tubular function. The mesangial matrix in glomeruli, a specialized stromal component, supports capillary loops and filters macromolecules, while its expansion in diabetic nephropathy impairs filtration efficiency. Podocytes, embedded in a stromal basement membrane, rely on stromal integrity to prevent proteinuria.
    • Connective Tissues (Extracellular Matrix as Stroma)
      Connective tissues, including bone, cartilage, and tendons, derive their mechanical properties from a fibrous stroma composed of collagen, elastin, and proteoglycans. Osteoblasts secrete an osteoid stroma that mineralizes to form bone, while chondrocytes in cartilage maintain a hydrated proteoglycan stroma for compressive resistance. Disruptions in stromal composition (e.g., mutations in collagen genes) lead to disorders like Ehlers-Danlos syndrome or osteogenesis imperfecta.
    • Nervous System (Neural Stroma and Glia)
      The neuroglial stroma provides structural support to neurons, regulates ion homeostasis, and participates in synaptic plasticity. Astrocytes, embedded in a glycogen-rich stroma, supply lactate to neurons during high metabolic demand, while the basement membrane stroma of blood vessels in the brain (blood-brain barrier) restricts pathogen entry.
    • Plant Vascular Tissues (Phloem and Xylem Parenchyma)
      In plants, the parenchymatous stroma of phloem and xylem supports long-distance transport of sugars and water. Companion cells in the phloem rely on a symplastic stroma (plasmodesmata-connected cytoplasm) to load sucrose into sieve tubes, while xylem parenchyma cells store reserves within a vacuolar stroma to sustain hydraulic conductivity.

    Stroma in Photosynthetic vs. Non-Photosynthetic Organisms: Evolutionary Divergences

    The stroma’s role in carbon fixation and energy conversion in photosynthetic organisms contrasts sharply with its functions in non-photosynthetic systems, reflecting distinct evolutionary pressures. In cyanobacteria and algae, the thylakoid-lumen stroma is optimized for the Z-scheme of photosynthesis, with a high concentration of RuBisCO and carbonic anhydrase to minimize photorespiration. The pyrenoid stroma in some algae (e.g., Chlamydomonas) further concentrates CO₂ via carbonic anhydrase, enhancing efficiency in low-CO₂ environments.

    In non-photosynthetic eukaryotes, stromal adaptations prioritize metabolic flexibility and structural resilience:

  • Fungi: The hyphal stroma contains septal pores for cytoplasmic continuity and glycogen reserves stored in vacuolar stroma, enabling rapid growth and stress responses.
  • Animals: The extracellular stroma (ECM) evolved to support multicellularity, with collagen-IV networks in basal laminae providing a scaffold for tissue polarity and fibronectin-rich stroma facilitating cell migration during development and wound healing.
  • Prokaryotes: Non-photosynthetic bacteria (e.g., Bacillus subtilis) rely on a cytoplasmic stroma enriched with heat-shock proteins and storage granules (e.g., polyhydroxyalkanoates) to survive nutrient scarcity and extreme conditions.
  • A key evolutionary divergence lies in the redox environment of the stroma:

  • Photosynthetic stroma: Maintains a reducing milieu (high NADPH/NADP⁺ ratios) to drive carbon assimilation.
  • Mitochondrial stroma: Operates under oxidizing conditions (high NAD⁺/NADH ratios) to sustain ATP production.
  • Extracellular stroma (animals): Balances oxidative and reductive microenvironments to regulate signaling (e.g., disulfide bond formation in the ECM vs. thiol redox buffers in the basement membrane).
  • Stromal Contributions to Tissue Architecture in Non-Plant Systems

    In non-plant systems, the stroma—whether cytoplasmic, organellar, or extracellular—serves as the biochemical and mechanical scaffold that defines tissue identity, resilience, and dynamic remodeling. Unlike plant cell walls, which provide rigid structural support, animal and fungal stromata prioritize elasticity, signaling, and metabolic plasticity. The extracellular matrix (ECM), a specialized stromal compartment in animals, is not merely a passive filler but an active participant in morphogenesis, immunity, and disease progression. Its components—collagens, proteoglycans, and matricellular proteins—orchestrate cell adhesion via integrins, modulate growth factor gradients, and resist mechanical stress through fibril alignment and cross-linking. For example, the laminin-rich stroma of the basement membrane polarizes epithelial cells, while the hyaluronan-rich stroma in cartilage absorbs compressive forces. Disruptions in stromal integrity, such as fibrosis or matrix metalloproteinase (MMP) hyperactivity, lead to pathological stiffening or degradation, underscoring its role as a thermodynamic and biomechanical regulator of tissue homeostasis.
    The stromal composition in non-plant systems also reflects species-specific adaptations:
  • Insect cuticle: A chitin-protein stroma provides exoskeletal support and waterproofing, with tanned proteins (sclerotin) enhancing rigidity.
  • Mushroom fruiting bodies: The hyphal stroma differentiates into spore-bearing structures via programmed cell death and glycoprotein deposition, optimizing spore dispersal.
  • Corneal stroma (eyes): A lamellar collagen stroma maintains transparency
  • what is stroma - Ilustrasi 2

    Biochemical Composition and Molecular Interactions of Stroma

    The stroma serves as a dynamic biochemical matrix within organelles such as chloroplasts, mitochondria, and the endoplasmic reticulum, where metabolic pathways converge to sustain cellular function. Its composition includes a complex interplay of enzymes, structural proteins, metabolites, and transport systems that collectively regulate energy conversion, biosynthetic processes, and molecular trafficking. The biochemical environment of the stroma is finely tuned to support specialized reactions, including carbon fixation in photosynthesis, nitrogen assimilation, and lipid synthesis, while maintaining metabolic homeostasis through precise regulatory mechanisms.

    The molecular architecture of the stroma integrates enzymatic catalysis, substrate availability, and transport-mediated exchange to ensure efficient metabolic flux. Key enzymes localize within the stroma to catalyze rate-limiting steps, while membrane-associated transport proteins facilitate the selective movement of ions, metabolites, and signaling molecules. This section examines the molecular components of the stroma, their catalytic roles, and the transport mechanisms that govern its biochemical environment.

    Enzymatic Composition and Catalytic Functions in Stroma

    The stroma hosts a diverse array of enzymes that drive central metabolic pathways, particularly in photosynthetic organisms. These enzymes are categorized based on their functional roles, including carbon assimilation, nitrogen metabolism, and redox regulation. The catalytic efficiency of stromal enzymes is often enhanced by their spatial organization within the matrix, proximity to substrate pools, and post-translational modifications that modulate activity in response to environmental cues.
    Key Enzymatic Pathways in Stroma:
  • Calvin-Benson Cycle (C3 Cycle): Facilitates carbon fixation in chloroplast stroma.
  • Nitrogen Assimilation: Reductive amination and transamination reactions convert inorganic nitrogen into amino acids.
  • Fatty Acid and Lipid Synthesis: Acetyl-CoA carboxylase and fatty acid synthase catalyze lipid biosynthesis.
  • Redox Homeostasis: Enzymes such as glutathione reductase and peroxiredoxins maintain thiol-disulfide balance.
  • The following table summarizes critical enzymes localized in the stroma, their catalytic functions, and associated metabolic pathways. The table highlights the biochemical diversity and functional specialization of stromal enzymes across different organelles and organisms.
    Enzyme Organelle/Tissue Localization Catalytic Function Metabolic Pathway Key Regulatory Features
    Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) Chloroplast stroma (C3 plants) Catalyzes carboxylation of RuBP to form two molecules of 3-phosphoglycerate (3-PGA) Calvin-Benson Cycle (Carbon Fixation) Most abundant enzyme on Earth; regulated by CO₂ concentration and activation via carbamylation
    Glutamine Synthetase (GS) Chloroplast stroma (photosynthetic tissues); Cytosol (non-photosynthetic tissues) Catalyzes ATP-dependent assimilation of ammonium (NH₄⁺) into glutamine Nitrogen Assimilation Allosterically regulated by metabolites (e.g., α-ketoglutarate, AMP); post-translationally modified by phosphorylation
    Acetyl-CoA Carboxylase (ACC) Chloroplast stroma (plastids); Cytosol (eukaryotes) Converts acetyl-CoA to malonyl-CoA, a rate-limiting step in fatty acid synthesis Lipid Biosynthesis Regulated by citrate activation and phosphorylation-mediated inactivation
    Glutathione Reductase (GR) Chloroplast stroma; Mitochondrial matrix Reduces oxidized glutathione (GSSG) to its reduced form (GSH) using NADPH Redox Homeostasis Critical for maintaining thiol redox balance; activity linked to photosynthetic electron transport
    Fructose-1,6-bisphosphatase (FBPase) Chloroplast stroma (photosynthetic organisms); Cytosol (non-photosynthetic eukaryotes) Hydrolyzes fructose-1,6-bisphosphate to fructose-6-phosphate, a gluconeogenic step Carbon Metabolism (Gluconeogenesis) Inhibited by 2,6-bisphosphoglycerate; activated by light in chloroplasts via thioredoxin-mediated reduction
    Nitrite Reductase (NiR) Chloroplast stroma (higher plants) Reduces nitrite (NO₂⁻) to ammonium (NH₄⁺) using ferredoxin as an electron donor Nitrogen Assimilation Dependent on photosynthetic electron transport; inhibited by high light and oxidative stress
    Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Chloroplast stroma; Cytosol (glycolysis) Catalyzes oxidative phosphorylation of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate Calvin-Benson Cycle / Glycolysis Regulated by light-dependent reduction of disulfide bonds in chloroplasts
    The enzymatic repertoire of the stroma reflects its role as a metabolic hub, where substrate channeling and cofactor availability are optimized for pathway efficiency. For instance, Rubisco’s abundance in the chloroplast stroma underscores its centrality to carbon fixation, while the coordination of GS and NiR in nitrogen assimilation exemplifies the stroma’s capacity to integrate multiple biosynthetic pathways. Post-translational modifications, such as phosphorylation or thiol redox changes, further fine-tune enzymatic activity in response to environmental or developmental signals.

    Transport Mechanisms Regulating Stromal Biochemistry

    The stroma’s biochemical environment is maintained through selective transport systems that regulate the influx and efflux of metabolites, ions, and signaling molecules. These transport mechanisms are mediated by membrane-embedded proteins, including channels, carriers, and translocators, which ensure substrate availability for stromal enzymes while preventing metabolic imbalance. In chloroplasts, the inner membrane acts as a permeability barrier, necessitating specialized transport proteins to facilitate the movement of metabolites between the stroma and other cellular compartments.
    Key Transport Processes in Stromal Biochemistry:
  • Photosynthetic Electron Transport: Ferredoxin and NADP⁺/NADPH shuttling between thylakoid lumen and stroma.
  • Carbon Metabolite Exchange: Triose phosphate/phosphate translocator (TPT) exports glycolytic intermediates to the cytosol.
  • Nitrogen Compound Transport: Glutamate/aspartate and amino acid carriers mediate nitrogen assimilation products.
  • Ion Homeostasis: H⁺/ATP and K⁺/H⁺ antiporters regulate stromal pH and osmotic balance.
  • The transport of metabolites into and out of the stroma is governed by three primary mechanisms:
    1. Channel-Mediated Diffusion: Facilitates passive movement of small molecules (e.g., CO₂ diffusion into the stroma for Rubisco).
    2. Carrier-Mediated Transport: Symporters, antiporters, and uniporters couple metabolite translocation with ion gradients or ATP hydrolysis (e.g., phosphate translocator).
    3. Translocator Complexes: Multi-subunit systems that coordinate the exchange of multiple metabolites (e.g., triose phosphate/phosphate translocator in chloroplasts).

    In chloroplasts, the triose phosphate/phosphate translocator (TPT) exemplifies a critical transport system that exports glycolytic intermediates (e.g., dihydroxyacetone phosphate, glyceraldehyde-3-phosphate) from the stroma to the cytosol in exchange for inorganic phosphate (Pi). This antiport mechanism is essential for balancing carbon partitioning between photosynthetic and respiratory pathways. Similarly, the phosphate translocator (PPT) ensures a steady supply of Pi for ATP synthesis and stromal metabolic reactions, linking photosynthetic electron transport to stromal biochemistry.

    Example of Stromal Transport Regulation:
    The starch synthase in the chloroplast stroma synthesizes starch from ADP-glucose, a process dependent on the availability of glucose-1-phosphate (G1P). G1P is generated from cytosolic glucose-6-phosphate via the glucose-6-phosphate/phosphate translocator (GPT), illustrating how stromal metabolism is coupled to cytosolic carbon fluxes through membrane transport.
    Mitochondrial stroma also relies on transport systems to maintain metabolic compartmentalization. The adenine nucleotide translocator (ANT

    Stroma’s Role in Cellular Energy and Metabolism

    The stroma serves as a central metabolic hub within chloroplasts, orchestrating the synthesis of organic molecules from inorganic substrates while integrating energy production with broader cellular demands. Its pivotal function extends beyond carbon fixation, encompassing the regulation of redox balance, ATP/NADPH supply, and the coordination of photosynthetic and respiratory pathways. The stroma’s biochemical versatility ensures that energy generated during light-dependent reactions is efficiently channeled into biosynthetic processes, sustaining plant growth, development, and stress responses. This section examines the stroma’s dual role in energy metabolism—its participation in the Calvin cycle and its integration with other cellular processes—while analyzing its adaptive efficiency under varying light conditions.

    The stroma’s metabolic network is intricately linked to the thylakoid lumen’s electron transport chain (ETC), forming a symbiotic relationship where light-driven proton gradients and redox reactions directly influence stromal enzyme activity. ATP and NADPH, the primary outputs of the light reactions, are not merely byproducts but critical substrates for the Calvin cycle, where they drive carbon assimilation into glucose-6-phosphate and other intermediates. Beyond photosynthesis, the stroma participates in secondary metabolism, amino acid synthesis, and lipid biosynthesis, demonstrating its multifunctional role in cellular energetics. The following sections dissect these processes, emphasizing the stroma’s regulatory mechanisms and its adaptive responses to environmental fluctuations.

    Integration of Stromal Metabolism with the Calvin Cycle

    The Calvin cycle, occurring entirely within the stroma, relies on the ATP and NADPH generated by the thylakoid’s photosynthetic electron transport chain to fix atmospheric CO₂ into organic molecules. This cycle is divided into three phases: carbon fixation (catalyzed by RuBisCO), reduction (using ATP and NADPH), and regeneration of the CO₂ acceptor ribulose-1,5-bisphosphate (RuBP). The stroma’s high concentration of enzymes, including RuBisCO, phosphoglycerate kinase (PGK), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), ensures efficient carbon processing.
    Key Enzymatic Steps in the Calvin Cycle:
    1. Carbon Fixation: CO₂ + RuBP → 2 × 3-phosphoglycerate (3-PGA) (catalyzed by RuBisCO).
    2. Reduction Phase: 3-PGA + ATP + NADPH → glyceraldehyde-3-phosphate (G3P) (via PGK and GAPDH).
    3. Regeneration Phase: G3P is rearranged to reform RuBP, consuming additional ATP.
    The stroma’s spatial organization minimizes diffusion limitations, allowing rapid substrate channelling between enzymes. For instance, the proximity of RuBisCO to the thylakoid membrane ensures immediate access to O₂ (a competing substrate for RuBisCO in photorespiration), while stromal NADP⁺-malic enzyme (in C₄ plants) recycles NADPH by converting malate to pyruvate. This integration highlights the stroma’s role in optimizing carbon assimilation while mitigating energy waste.

    Step-by-Step ATP and NADPH Production in Stroma-Dependent Photosynthesis

    The stroma’s metabolic outputs are directly tied to the thylakoid’s light reactions, where water photolysis in Photosystem II (PSII) releases electrons, protons, and O₂. These electrons traverse the ETC via plastoquinone (PQ), the cytochrome b₆f complex, and plastocyanin (PC), ultimately reducing NADP⁺ to NADPH in Photosystem I (PSI). The proton gradient generated across the thylakoid membrane drives ATP synthesis via CF₀-CF₁ ATP synthase, exporting protons into the stroma.
    1. Light Absorption and Water Splitting:
      Photons excite chlorophyll in PSII, splitting H₂O into O₂, 2H⁺, and 2e⁻. The released electrons enter the ETC, while protons accumulate in the thylakoid lumen.
    2. Electron Transport Chain (ETC) and Proton Gradient Formation:
      Electrons move through PQ → cytochrome b₆f → PC, reducing PC to PC⁺. The cytochrome b₆f complex pumps additional H⁺ into the lumen, steepening the gradient.
    3. NADPH Generation in PSI:
      Excited electrons from PC reduce ferredoxin (Fd) in PSI, which then reduces NADP⁺ to NADPH via ferredoxin-NADP⁺ reductase (FNR). NADPH diffuses into the stroma for the Calvin cycle.
    4. ATP Synthesis via Chemiosmosis:
      The proton gradient drives H⁺ back into the stroma through CF₀-CF₁, synthesizing ATP from ADP + Pi. ATP is exported to the stroma for use in the Calvin cycle.
    5. Stromal Utilization:
      ATP and NADPH power the reduction of 3-PGA to G3P, with excess NADPH also supporting anabolic pathways like nitrate reduction (for amino acid synthesis) or sulfur assimilation.
    The stroma’s high [Mg²⁺] and pH (~8.0) further activate Calvin cycle enzymes, ensuring optimal catalytic efficiency. For example, RuBisCO’s carboxylation activity peaks at pH 8.0, aligning with stromal conditions post-ATP synthesis.

    Flowchart of Stromal Metabolic Outputs and Cellular Energy Integration

    The stroma’s metabolic outputs feed into a hierarchical network that sustains cellular energy demands, from primary carbon fixation to secondary metabolism and growth. Below is a structured representation of these pathways:
    Primary Metabolic Hubs in the Stroma:
  • Carbon Assimilation: Calvin cycle → G3P → sucrose/starch synthesis.
  • Redox Balance: NADPH supports nitrate reductase (NR) and glutathione reductase (GR).
  • Amino Acid Synthesis: G3P → serine → glycine/cysteine; NADPH reduces nitrite (NO₂⁻) to NH₄⁺.
  • Lipid Biosynthesis: G3P → glycerol-3-phosphate → phospholipids/triglycerides.
  • Stress Responses: NADPH regenerates ascorbate (via monodehydroascorbate reductase) to scavenge reactive oxygen species (ROS).
    1. Calvin Cycle Outputs:
      • G3P → Export to cytosol for sucrose synthesis (via sucrose-phosphate synthase) or starch storage in amyloplasts.
      • Excess G3P enters the oxidative pentose phosphate pathway (OPPP) to generate NADPH for reductive biosynthesis.
    2. Energy Coupling with Mitochondria:
      • Stromal malate (from C₄ plants) is decarboxylated in mitochondria, supplying NADH for the TCA cycle.
      • ATP/NADPH from the stroma supports mitochondrial electron transport, linking photosynthesis and respiration.
    3. Secondary Metabolism:
      • NADPH reduces precursors for flavonoid, alkaloid, and terpenoid synthesis (e.g., shikimate pathway).
      • ATP powers active transport of metabolites (e.g., amino acids into vacuoles).
    4. Stress Adaptation:
      • Under oxidative stress, stromal ascorbate-glutathione cycle (water-water cycle) detoxifies H₂O₂ using NADPH.
      • Low-light conditions trigger alternative electron sinks (e.g., cyclic photophosphorylation) to maintain ATP/NADPH ratios.
    This flowchart underscores the stroma’s role as a metabolic crossroads, where photosynthetic energy is allocated to growth, defense, and repair based on environmental cues.

    Metabolic Efficiency of Stroma Under Varying Light Conditions

    The stroma’s metabolic efficiency is dynamically regulated by light intensity, which influences electron transport rates, enzyme activation, and substrate availability. Under high-light conditions, the stroma experiences:
  • Increased ATP/NADPH Production: Elevated ETC activity maximizes photophosphorylation, but excess NADPH can lead to photodamage if not utilized.
  • Enhanced Calvin Cycle Activity: RuBisCO and PGK operate near saturation, but O₂ competition (photorespiration) rises, diverting energy from carbon fixation.
  • Adaptive Responses:
    • Non-Photochemical Quenching (NPQ): Excess energy is dissipated as heat via xanthophyll cycles, protecting PSII.
    • Alternative Electron Pathways: Chlororespiration (via PGR5-dependent cyclic electron flow) sustains ATP synthesis without NADPH overproduction.
    • Starch Accumulation: Excess G3P is stored as transient starch, buffering carbon flux.
    Conversely, low-light conditions impose constraints:
  • Limited ATP/NADPH Supply: Reduced ETC activity slows the Calvin cycle, leading
  • what is stroma - Ilustrasi 3

    Stroma in Disease and Medical Research

    Disruptions in stromal function represent a critical yet underappreciated dimension of pathology, influencing metabolic, neurodegenerative, and fibrotic diseases through alterations in cellular architecture, biochemical signaling, and energy homeostasis. The stroma’s role as a dynamic scaffold—mediating nutrient transport, waste clearance, and structural integrity—positions it as both a contributor to disease progression and a potential therapeutic target. Emerging research demonstrates that stromal dysfunction underlies conditions ranging from mitochondrial disorders to cancer-associated fibrosis, where extracellular matrix (ECM) remodeling and metabolic reprogramming exacerbate tissue dysfunction. This section examines the pathological mechanisms linking stromal abnormalities to disease, outlines experimental models dissecting these processes, and explores therapeutic interventions targeting stromal components.

    Pathological Mechanisms of Stromal Dysfunction

    Stromal abnormalities contribute to disease through mechanical stress, biochemical imbalance, and signaling disruption. In metabolic disorders such as diabetes and obesity, stromal fibrosis in adipose tissue impairs insulin signaling and adipokine secretion, while mitochondrial dysfunction in stromal cells (e.g., fibroblasts) reduces ATP production and increases reactive oxygen species (ROS). Neurodegenerative conditions like Alzheimer’s disease exhibit altered stromal composition in the central nervous system, where amyloid-beta accumulation disrupts ECM integrity and neurovascular coupling. Additionally, stromal remodeling in cancer—characterized by desmoplasia and altered stromal-epithelial interactions—facilitates tumor progression by promoting angiogenesis, immune evasion, and metabolic symbiosis between cancer cells and stromal fibroblasts.

    Key pathological pathways include:

  • Extracellular Matrix (ECM) Dysregulation: Excessive deposition or degradation of collagen, laminin, and fibronectin alters tissue stiffness and cellular adhesion, as observed in idiopathic pulmonary fibrosis (IPF) and liver cirrhosis.
  • Mitochondrial-Stromal Crosstalk: Impaired mitochondrial function in stromal cells (e.g., due to mutations in POLG or SURF1) disrupts redox homeostasis, exacerbating oxidative stress in metabolic and neurodegenerative diseases.
  • Autophagy Defects: Stromal autophagy dysfunction, linked to mutations in ATG5 or LC3, accumulates damaged organelles and proteins, contributing to lysosomal storage disorders and aging-related pathologies.
  • Inflammatory Stromal Remodeling: Chronic inflammation in stromal cells (e.g., via NF-κB or TGF-β signaling) promotes fibrosis and tissue scarring, as seen in rheumatoid arthritis and systemic sclerosis.
  • Experimental Models for Studying Stromal Pathologies

    Genetic, pharmacological, and organoid models have elucidated the role of stromal dysfunction in disease. Below is a table summarizing key experimental approaches, their applications, and limitations.
    Model Type Disease Focus Key Genetic/Pharmacological Modifications Key Findings Limitations
    Genetic Knockout Mice Metabolic Disorders (e.g., Diabetes, Obesity)
    • Col1a1 or Col3a1 knockout → Altered ECM stiffness in adipose tissue.
    • Tgf-β1 overexpression → Fibrosis in liver and lung.
    • Sirt1 deletion → Impaired mitochondrial biogenesis in stromal fibroblasts.
    • Revealed stromal fibrosis as a driver of insulin resistance.
    • Demonstrated TGF-β’s role in organ-specific fibrogenesis.
    • Linked stromal Sirt1 to metabolic aging and ROS production.
    Species-specific differences in stromal composition; limited translational relevance to human disease.
    Inducible Stromal-Specific Knockdown Neurodegenerative Diseases (e.g., Alzheimer’s, Parkinson’s)
    • ApoE or Tau overexpression in astrocytes → Amyloid plaque-associated stromal remodeling.
    • Parkin knockout in stromal cells → Mitochondrial dysfunction in neurovascular units.
    • Identified stromal ApoE as a modulator of amyloid clearance.
    • Showed Parkin’s role in maintaining stromal mitochondrial integrity in neurodegeneration.
    Technical challenges in cell-type-specific induction; variable penetrance.
    Organoid Systems (e.g., Fibroblast-Derived Organoids) Fibrotic Diseases (e.g., IPF, Liver Cirrhosis)
    • YAP/TAZ activation → Mimics mechanical stress-induced fibrosis.
    • TGF-β signaling inhibitors → Reverses ECM stiffening in 3D cultures.
    • Recapitulated patient-derived stromal fibrosis in vitro.
    • Enabled high-throughput screening of antifibrotic drugs.
    Lack of vascularization and immune cell interactions; limited long-term stability.
    Pharmacological Inhibition Models Cancer-Associated Stroma (e.g., Pancreatic Ductal Adenocarcinoma)
    • Hedgehog pathway inhibitors (e.g., Sonidegib) → Reduces desmoplastic stroma.
    • LOX (lysyl oxidase) inhibitors → Prevents ECM cross-linking.
    • Demonstrated stromal targeting as a strategy to improve chemotherapeutic delivery.
    • Revealed LOX-dependent stiffness as a barrier to immunotherapy.
    Off-target effects; transient responses in vivo.

    Therapeutic Strategies Targeting Stromal Dysfunction

    Stromal-targeted therapies aim to restore biochemical balance, mechanical homeostasis, and signaling integrity. Approaches include enzyme replacement, gene editing, drug repurposing, and biomaterial-based interventions.

    Enzyme Replacement and Small-Molecule Therapies
    Stromal dysfunction in lysosomal storage disorders (e.g., Fabry disease) is addressed via enzyme replacement therapy (ERT), where recombinant α-galactosidase A restores lysosomal function in stromal cells, reducing substrate accumulation and fibrosis. Similarly, mitochondrial-targeted antioxidants (e.g., MitoQ) mitigate ROS-induced stromal damage in metabolic diseases. In fibrosis, pirfenidone and nintedanib inhibit TGF-β/Smad signaling, reducing ECM deposition in IPF patients, though their efficacy is limited by off-target effects.

    Gene Editing for Stromal Correction
    CRISPR-Cas9 and base editing are being explored to correct stromal genetic defects. For example:

  • In vivo base editing of the COL1A1 gene in fibrotic mice reduced collagen overproduction without off-target effects (Nature Biotechnology, 2021).
  • AAV-mediated delivery of SOD2 (superoxide dismutase) to stromal cells in Parkinson’s disease models attenuated neuroinflammation (Journal of Clinical Investigation, 2022).
  • Challenges include delivery efficiency, immune responses, and long-term safety.

    Biomaterial and Mechanical Interventions
    Biodegradable hydrogels (e.g., PEG-based matrices) are designed to mimic native stromal stiffness, guiding tissue regeneration in wound healing and fibrosis. For instance, soft hydrogels implanted in fibrotic lungs reduce myofibroblast activation by normalizing mechanical cues (Science Translational Medicine, 2020). Additionally, piezoelectric materials are under investigation to modulate stromal cell mechanotransduction in cardiac fibrosis.

    Immunomodulatory Approaches
    Stromal cells regulate immune cell infiltration via chemokines (e.g., CXCL12, CCL2). Monoclonal antibodies targeting stromal-derived factors (e.g., anti-CXCR4 for metastatic cancer) or CAR-T cells engineered to degrade fibrotic ECM (e.g., via ADAMTS overexpression) are emerging strategies to disrupt tumor-stroma interactions.

    Imaging Stromal Abnormalities in Disease

    Advanced imaging techniques reveal structural and compositional alterations in stroma associated with specific pathologies. Electron microscopy (EM) and super-resolution microscopy provide nanoscale insights into ECM organization, mitochondrial ultrastructure, and lysosomal morphology.

    Key Imaging Modalities and Findings

  • Transmission
  • Stroma in Biotechnology and Synthetic Biology

    The stroma, traditionally recognized as the metabolic hub of chloroplasts and mitochondria, has emerged as a versatile biological scaffold in biotechnology and synthetic biology. Its biochemical properties—including high enzyme density, compartmentalized metabolic pathways, and adaptable redox environments—enable efficient substrate conversion, metabolite channeling, and cofactor recycling. These attributes are increasingly exploited to engineer microbial and plant cell factories for biofuel production, pharmaceutical biosynthesis, and sustainable chemical synthesis. Synthetic biology leverages stroma-like systems to repurpose natural metabolic networks, integrate heterologous pathways, and optimize bioreactor performance through computational modeling and metabolic flux analysis.

    The design of stroma-inspired biocatalytic platforms relies on three key strategies: pathway compartmentalization, cofactor regeneration, and spatial organization of enzymes. Compartmentalization mimics the natural stroma by localizing enzymes within synthetic organelles (e.g., synthetic peroxisomes or chloroplast-derived thylakoid membranes) to minimize side reactions and enhance substrate specificity. Cofactor regeneration systems, such as NAD(P)H-recycling modules, are integrated to sustain redox-dependent reactions, while spatial organization—achieved through scaffold proteins or phase-separated droplets—enhances catalytic efficiency by reducing diffusion limitations.

    Exploitation of Stroma’s Biochemical Properties in Bioengineering

    The stroma’s role in carbon fixation, nitrogen assimilation, and secondary metabolite production provides a blueprint for designing self-sustaining biocatalytic systems. For instance, the Calvin-Benson-Bassham (CBB) cycle, localized in the chloroplast stroma, has been repurposed in E. coli and cyanobacteria to produce biohydrogen via engineered hydrogenases coupled to photosynthetic electron transport chains. Similarly, the glyoxylate shunt—a stromal pathway in plants—has been introduced into Saccharomyces cerevisiae to improve lipid accumulation from acetate, a key step in biodiesel production.

    In pharmaceutical biosynthesis, stromal enzymes such as geranylgeranyl pyrophosphate synthase (GGPPS) and monoterpene cyclases are heterologously expressed in microbial hosts to synthesize high-value compounds like artemisinic acid (a malaria treatment precursor) and taxadiene (a taxol intermediate). The compartmentalization of these pathways within engineered stroma-like environments reduces toxicity from intermediate metabolites and improves yield. For example, targeting the mevalonate pathway to the chloroplast stroma in Nicotiana benthamiana increased amorphadiene production by 50% compared to cytoplasmic expression.

    Key biochemical properties exploited in bioengineering:

  • High enzyme density: Stromal enzymes operate at near-physiological concentrations, enabling high flux through metabolic pathways.
  • Cofactor availability: NAD(P)H, ATP, and ferredoxin pools in the stroma are harnessed for redox-dependent reactions.
  • Metabolite channeling: Multienzyme complexes (e.g., pyruvate dehydrogenase) minimize intermediate loss and enhance pathway efficiency.
  • pH and redox buffering: The stroma’s mildly alkaline environment (pH ~8.0) and reducing potential support labile intermediates like thioredoxin-regulated enzymes.
  • Synthetic Biology Applications of Stroma-Based Systems

    The modular nature of stromal pathways allows their repurposing for diverse synthetic biology applications. Below are key examples where stroma-inspired designs enhance bioprocessing:
    • Biofuel Production
      Stroma-derived pathways, such as the CBB cycle and glycolate pathway, are engineered into cyanobacteria and algae to produce bioethanol, biobutanol, and triacylglycerols (TAGs). For example, Synechococcus elongatus with a modified CBB cycle achieves 30% higher carbon conversion efficiency into ethanol when coupled with stromal pyruvate decarboxylase.
    • Pharmaceutical Synthesis
      Stromal enzymes like cytochrome P450s and UDP-glucosyltransferases are used to synthesize artemisinin, resveratrol, and morphine alkaloids. In Arabidopsis thaliana, expressing retroaldolase in the chloroplast stroma enabled production of 1,3-propanediol from glycerol, a platform chemical for polymers.
    • Bioremediation and Bioplastics
      Stroma-localized dehalogenases and polyhydroxyalkanoate (PHA) synthases degrade toxic compounds (e.g., polychlorinated biphenyls) and produce biodegradable plastics. E. coli with a stroma-targeted PHA pathway accumulated 80% more PHA when enzymes were anchored to thylakoid membranes.
    • Agricultural Enhancements
      Stromal engineering improves crop traits by optimizing photosynthetic efficiency and stress tolerance. For instance, introducing carbonic anhydrase into the stroma of rice increased CO₂ fixation by 25%, while expressing sodium/proton antiporters enhanced salt tolerance in Arabidopsis.
    • Synthetic Organelles
      Artificial stroma-like compartments are created using protein scaffolds (e.g., ELP-based droplets) or lipid vesicles to encapsulate metabolic pathways. These systems enable orthogonal biosynthesis, where non-native pathways operate independently of host metabolism. For example, a synthetic stroma in E. coli containing isoprenoid biosynthesis enzymes produced squalene at yields comparable to yeast systems.

    Comparison of Natural vs. Engineered Stroma-Like Environments in Bioreactors

    The design of engineered stroma-like systems in bioreactors balances natural metabolic efficiency with industrial scalability. Below is a comparative analysis of key parameters:
    Parameter Natural Stroma (Chloroplast/Mitochondria) Engineered Stroma-Like Systems Bioreactor Implementation
    Compartmentalization Double-membrane-bound; thylakoid lumen separation for light-dependent reactions. Synthetic organelles (e.g., ELP droplets, lipid vesicles) or scaffold-based microcompartments. Encapsulation in polyethylene glycol (PEG)-based coacervates or magnetic nanoparticle scaffolds for spatial control.
    Enzyme Localization Targeting via transit peptides; redox-sensitive enzymes (e.g., thioredoxin-regulated). Affinity tags (e.g., His-tags, SpyTag) or split-protein systems for modular assembly. Use of chitin-binding domains to anchor enzymes to immobilized chitosan beads in bioreactors.
    Cofactor Regeneration NADPH from light reactions; ATP via ATP synthase. Engineered NADPH-recycling cycles (e.g., glucose-6-phosphate dehydrogenase) or formate dehydrogenase for in situ NADH regeneration. Integration of electrochemical cofactor regeneration in microbial fuel cell-coupled bioreactors.
    Metabolic Flux Control Dynamic regulation via post-translational modifications (e.g., phosphorylation). Small-molecule inducers (e.g., IPTG for T7 promoters) or quorum sensing systems for tunable expression. Feedback loops using CRISPR-based metabolic sensors to adjust pathway flux in real time.
    Scalability Limited by plant/microbial growth rates and organelle density. Modular designs allow stackable pathways (e.g., multi-enzyme cascades in one compartment). Continuous-flow membrane bioreactors with immobilized stroma-like vesicles for high-throughput production.
    Stability and Containment Protected by cellular membranes; prone to oxidative damage. Stabilized via cross-linking (e.g., sortase-mediated) or encapsulation in silica nanoparticles. Use of perfluorocarbon emulsions to protect enzymes from shear stress in turbulent bioreactors.
    Examples of Applications Photosynthesis, nitrogen

    Stroma exemplifies the intricate balance between structure and function in cellular biology, where its biochemical environment enables life-sustaining processes while remaining adaptable to evolutionary pressures and experimental manipulation. From powering photosynthesis in chloroplasts to influencing tissue architecture in animals, its versatility underscores a unifying principle across diverse organisms. As research progresses, stroma’s potential in disease mitigation—through targeted therapies—and biotechnological applications—such as biofuel production—continues to expand, cementing its status as a cornerstone of modern biological and medical science. Understanding stroma is not merely an academic pursuit but a gateway to unlocking solutions for some of humanity’s most pressing challenges in health and sustainability.

    FAQ

    What exactly is the stroma in a chloroplast, and what role does it play?

    The stroma is the fluid-filled space inside the chloroplast membrane, surrounding the thylakoids. It contains enzymes, DNA, and ribosomes and is where the Calvin cycle (light-independent reactions) occurs to produce sugars from carbon dioxide and water.

    What are stromatolites, and how are they formed?

    Stromatolites are layered sedimentary structures formed by microbial communities, primarily cyanobacteria, trapping and binding sediment in shallow water. They are among Earth’s oldest fossil records (dating back ~3.5 billion years) and provide clues about early life and oxygen production.

    What are stromal cells, and where in the body are they found?

    Stromal cells are connective tissue cells that provide structural and functional support to functional cells (e.g., parenchymal cells). They are found in organs like the bone marrow, breast tissue, and blood vessels, often forming the "scaffolding" that regulates tissue growth and immunity.

    What are stroma lamellae, and how do they differ from grana in chloroplasts?

    Stroma lamellae are unstacked thylakoid membranes connecting grana stacks within chloroplasts. Unlike grana (which maximize light absorption via stacking), stroma lamellae facilitate efficient electron transport between grana and the stroma, ensuring smooth energy flow during photosynthesis.

    What is the stroma in the ovary, and what functions does it serve?

    The ovarian stroma is the connective tissue framework surrounding follicles and corpus luteum. It produces hormones (e.g., androgens), supports follicle development, and contributes to the structural integrity of the ovary, while also playing a role in menstrual cycle regulation.

    What is stromal fibrosis, and what causes it in organs like the liver or lungs?

    Stromal fibrosis is the excessive buildup of fibrous connective tissue in an organ’s stroma, often due to chronic injury, inflammation, or scarring. Causes include prolonged inflammation (e.g., hepatitis in the liver), radiation therapy, or genetic disorders, leading to organ stiffness and impaired function.

    Leave a Comment

    Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.